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Summary
The immunoregulatory cytokine interleukin 6 (1176) directly upregulates production of human
immunodeficiency virus (HIV) in acutely as well as in chronically infected cells of monocytic
lineage. In addition, 11,6 synergizes with tumor necrosis factor a (TNF-a) in the induction
of latent HIV expression. Unlike TNF-a, upregulation ofviralexpression induced by IL6 alone
does not occur at the transcriptional level and it is not associated with accumulation of HIV
RNA. However, when IM and TNF-ci synergistically stimulate HIV production, accumulation
of HIV RNA and increased transcription are observed, indicating that IMaffects HIV expression
at multiple (transcriptional and post-transcriptional) levels.
H
IV, the causative agent of AIDS, can infect and persist
in the CD4+ cells of the immune system, such as T
lymphocytes and mononuclear phagocytes (1). A number of
mechanisms have been recently delineated whereby virus ex
pression is upregulated in infected cells (reviewed in refer-
ence 1) . Of particular interest is the fact that the virus can
utilize a number of cell-derived soluble factors or cytokknns
for this purpose. In this regard, it has recently been demon-
strated that cytokine-rich crudesupernatants ofmononuclear
cells (2, 3), as well as recombinant cytokines such as TNF-a
(4, 5) and -ß (4) and granulocyte/macrophage colony-stim-
ulating factor (GM-CSF)t (2, 6), can induce expression of
virus in HIVinfected cells. It is noteworthy that this virus,
which utilizes a functionally important molecule (CD4) on
the surface of immune competent target cells as its receptor
for cell entry (7), has also evolved cellular mechanisms for
the upregulation of its expression by certain cytokines opera-
tive in thenormal homeostatic control ofthe immune system.
Furthermore, the molecular pathway(s) whereby HIV up-
regulation is accomplished for certain cytokines such as TNF
is similar to the molecular mechanisms that modulate the
expression of cellular gene function (8, 9). Specifically, TNF
' Abbreviations used in this paper. Ab, antibody; GM-CSF, granulocyte/
macrophage colony-stimulating factor; HTLV--1, human T lympho-
tropic virus 1; IMDM, Iscove's modified Dulbecco's medium; LTR,
long terminal repeat; MDM, monocyte-derived macrophages; RT,
reverse transcriptase.
induction of HIV expression utilizes the pleiotropic cellular
transcription factor NF-kB (9), which binds to the core en-
hancer region ofthe HIV long terminal repeat (LTR) (10-13).
Ofparticular interest in the humanimmunoregulatory net-
work is the cytokine IL-6, which has a broad range of effects
on the regulation of the immune system (14, 15). IL-6 is also
known as B cell stimulatory factor 2 (16), hybridoma/plas-
macytoma growth factor (17), hepatocyte-stimulating factor
(18), IFN-ß2 (19), and 26kD protein (20). Synthesis of 1176
is inducible in many cell types (reviewed in references 14 and
15), including mononuclear phagocytes and T lymphocytes.
Among the several conditions whereby synthesis of IL6 is
induced, infection of T lymphocytes with the human T lym-
photropic virus 1 (HTLV1) (20), and cell stimulation by
cytokknns such TNF-cY (21) and ILA (22), are of particular
interest. Among its several functions (14, 15), 1176 induces
terminal differentiation of lymphocytes to plasma cells (23)
and proliferation of precursor and mature T cells (24), and
acts as an autocrine growth factor for multiple myelomas/
plasmacytomas (25, 26).
With regard to the relationship of this cytokine to HIV,
in vitro infection of normal monocyte/macrophages with
HIV-1 has been found to induce gene expression and secre-
tion of 11,6 (27). In addition, increased levels of IL6 have
been recently reported both in the serum (28) and in the
cerebrospinal fluid (29) of HIV-infected patients. Thus, it is
important to determine whether this cytokine is capable of
directly affecting the expression ofHIV in infected cells and/or
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other cytokines.
In thepresent studywe demonstrate that 11,6 directly stimu-
latesHIV replication in primaryhumanmacrophages acutely
infected in vitro. In addition, 11.,6 induces HIV expression
in chronically infectedpromonocytic cells and synergizes with
TNF-a in this effect. Furthermore, at the molecular level,
we provide evidence that IIr6 induction of HIV expression
involves multiple and diverse mechanisms.
Materials and Methods
Infection ofPrimary Monocyte-derived Macrophages (MD*.
￿
Hep-
arinized venous peripheral bloodfrom healthy seronegative donors
was diluted 1:4 with cold PBS and subjected to Ficoll-Hypaque
gradient (550 gfor30 min at 4°C) in order to separate themono-
nuclear cell fraction (PBMC). PBMC were carefully resuspended
in cold PBSand washed twice (350 g for 10 min at 4°C) in order
to reduce platelet contamination. Finally, PBMC were resuspended
in Iscove's Modified Dulbecco's Medium (IMDM; Gibco Labora-
tories, Grand Island, NY) containing 10% FCS (basic medium).
The bacterial endotoxin (LPS) content of the medium and FCS
was<3 pg/ml, and <400 pg/ml, respectively. Then, N2 x 10, cells/
ml/well were plated in 24-well plastic tissue culture plates (Costar,
Cambridge, MA). After overnight incubation at 37°C in hu-
midified, 5% CO2 atmosphere, nonadherent cells (highly enriched
in T lymphocytes) were removed by vigorous pipetting. The re-
mainingadherent cells(predominantly monocytes) were maintained
in culturein thepresence or absence of 100U/ml ofrIL6, or TNF-cY,
or GM-CSF for an additional 5-7 d before infection with amacro-
phage-tropic strain ofHIV (AD-87) (30).TheLPScontents of these
cytokine concentrations were <0.1 pg/ml. No significant differences
in comparison to adherence-purified monocyteswere observed when
monocytes were purified by countercurrent centrifugal elutriation
andinfected with HIV Approximately 50% oftheculture superna-
tants was replaced with basic medium or medium containing cyto-
kinesevery 5-7 d after HIV infection for several weeks. In parallel
experiments, theautologous nonadherent (T lymphocyte-enriched)
cellswere maintained and infected with HIVin similarculture con-
ditions. PHAstimulated T cell blasts were also infected with a
T lymphocytotropic HIV strain (LAV) and. were maintained in cul-
ture in medium containing IIr2 (31) plus additional cytokines.
HIVinfected Cell Lines.
￿
The chronically HIVinfected Ul cell
line was obtained by limiting dilution cloning of promonocytic
U937 cells that survived an acute HIV-1 infection (32). U1 cells
possess two integrated copies of HIV proviral DNA (Maury W.,
and A. Rabson, personal communication) and constitutively ex-
presslow levels ofvirus as determined by immunofluorescence, cel-
lular and supernatant-associated reverse transcriptase (KT) activity,
HIV p24antigencapture, Western blot and Northern blot analysis
(32-34). Upregulation of HIV expression in U1 cells is induced
by PMA(32),cytokine-enriched supernatants (2), andrecombinant
cytokines such as TNF-a (34, 35), and GM-CSF (2). In addition,
a second chronically infected clone of U937, U33.3 (34), and the
chronically infected CEM-derived ACH-2 T lymphocytic cell line
(3, 34, 36), which are also inducible by PMA and TNF-a, were
tested in response to 11,6.
Cytokines andAnticytokine Antibodies (Abp
￿
Various cell lineswere
stimulated with recombinant human (rh) IL6(Amgen Biologicals,
ThousandsOaks, CA), rhTNF-a, andrhGM-CSF (Genzyme Corp.,
Boston, MA) in aconcentration rangebetween 0.1 and 1,000 U/ml.
Typically, 2.5 x 101 cells/ml were resuspended in RPMI 1640
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(M. A. Whitaker Bioproducts, Walkersville, MD) containing 10%
FCS, plated in 24- or 96-well plates (Costar) in the presence or
absence of cytokines, and were maintained at 37°C in 5% C02.
Aliquots of the culture supernatants were harvested daily up to
6 d afterstimulation, stored at -70°C, thawed, andtested for RT
activity. Goat polyclonal andmurine monoclonal anti-IL6 Ab (R
& D System, Minneapolis, MN) were tested for their ability to
suppress the induction of HIV production by various cytokines.
Rabbit polyclonal anti TNF-a Ab (a kind gift of Dr. Renato Ber-
nardini, University ofCatania, Italy, andSamuel Listwak, NIMH,
NIH, Bethesda, MD), and monoclonal antiTNF-a Ab (Olympus,
Lake Success, NY)were also tested for their ability to suppress HIV
expression.
RT Assay.
￿
Aliquots of supernatants from cytokine-stimulated
andunstimulated cultures were tested forthe presence of HIV RT
by the method of Willey et al. (37) . 10 Al of supernatants were
added in duplicate to 50 Al of a mixture containing poly(A),
oligo(dT) (Pharmacia Fine Chemicals, Piscataway, NJ), MgCl2,
and '2P-labeled deoxythymidine 5'-triphosphate (dTTP) (Amer-
sham Corp., Arlington Heights, IL), andincubatedfor2hat 37°C.
6 EAl of the mixture was spotted onto DE81 paper (Whatman In-
ternational, Maidston, England), air-dried, washed five times in
2x SSCbuffer, andtwoadditional timesin 95% ethanol. Thepaper
was then dried, cut, and counted on a scintillation counter (No.
LS 7000; Beckman Instruments, Fullerton, CA).
Western Blot Analysis.
￿
Celllysates were prepared from Ul cells
incubated for 72 h in the presence or absenceof 100 U/ml ofIL6,
100U/ml ofTNF-a, or thecombination ofboth cytokines. 20 141
from the lysate of 10' cells was added to each lane andsubjected
to electrophoresis through 10-20% gradient polyacrylamide gels
(Integration Separation Sciences, Hyde Park, MA) for 6 h. The
migrated proteins were then transferred overnight onto nitrocellu-
lose filters. Aftersaturation with a 5% milk solution, filters were
incubatedfor 2hwith 1:1,000vol/vol dilution ofan AIDS patient
serum containing high titers of anti-HIV Ab recognizing most
of the majorviral proteins (33). Filters were then washed and in-
cubatedfor90 minwith "II-labeled protein A (200,000 dpm/ml),
washed, air-dried, and exposed overnight to x-ray film, as previ-
ously described (33).
Northern Blot Analysis.
￿
Ul cellswere resuspended at 2.5 x 101
cells/ml andmaintained in RPMI 1640 with 10% FCSin thepres-
ence or absenceof various cytokines. TotalRNAwas extractedby
theguanidine thiocyanate phenol method with an RNA Isolation
Kit (Stratagene, La Jolla, CA) from 108 Ul cells after 24, 48, and
72 h ofcytokine stimulation. 10 hg of totalRNA was loaded per
lane on a0.8% agarose formaldehyde gelandtransferred to nitrocel-
lulose by Northern blotting. Thefilters were bakedandhybridized
for 12 h with a "P-labeled HIVLTR (HindIII-Aval) probe. Filters
were washed and exposed to radiographic film. Thelabeled probe
was removed from the filters by washing at 80°C in 0.1 x SSC,
containing 0.1% SDS and then rehybridized with a "P-labeled
/3-actin cDNA probe. The results were confirmed by RNA slot
blot analysis (12).
Nuclear Run-On Analysis.
￿
Nuclei from 5 x 10' U1 cells were
isolated 17 haftercytokine stimulation andnuclear run-on analysis
were performed according to a published procedure (38). Briefly,
equal amounts of '1P-labeled RNA (10' cpm/0.8 ml) were hybrid-
ized to linearizedplasmidDNAprobes immobilized on nitrocellu-
lose filters. Probes included PBR 322 or PUC 19 as plasmid con-
trols, pNL4-3, which is a plasmid containing a full-length HIV
genome (39), and human 0-actin cDNA. Filters were exposedto
x-rayfilm forvarious timesup to 7danddensitometriclaser scan-
ning wasperformedon thedifferentautoradiograms usingan LKB2222-10 densitometer. The densitometric measurements of HIV
were normalized to those of the #-actin controls.
Results
Different Cytokines Upregulate HIV Replication in Acutely
Infected PrimaryMDM . MDM cultures exposed to various
concentrations of certain recombinant cytokines showed an
increase inHIV replication. As previously reported (6), GM-
CSF enhanced HIV production in primary infected MDM
(Fig . 1 A) . Similarly, both TNT-a (Fig . 1 A) and IL6 (Fig.
1,A and B) were effective in upregulating HIV replication
inMDM . Worthy ofnote is the fact that a significant degree
ofvariability was observed between different monocyte donors
in terms of susceptibility to HIV infection (with levels of
peak HIV production in the absence of exogenous rytokine
stimulation ranging between 300 and 12,000 rpm/Al), prob-
ably reflecting different levels ofin vivo activation and/or differ-
ences in individual susceptibility to HIV infection, as previ-
ously observed for T lymphocytes (31) . Nonetheless, IIT6,
and to a lesser extent TNF-a andGM-CSF, reproducibly in-
creased HIV expression in MDM . 5 of 5 donors' infected
Figure 1 .
￿
Cytokine upregulation of viral replication in primary
human MDM infected in vitro with HIV (A) The RT levels shown
are representative of the peak amount of HIV produced at day 15
postinfection by the MDM obtained from a single donor. Variability
among replicate cultures was <20%. Cytokine concentrations : 100
U/ml. (B) Typical kinetics of virus production in unstimulated MDM
and MDM stimulated with 11,6 (100 U/ml) .
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MDM showed higher peakRT levels and accelerated kinetics
of viral replication as compared with unstimulated cells, as
shown in Fig. 1 B . In contrast, IL6 did not show any sig-
nificant effect on HIV infection of primary T lymphocytes
eitherwhen cells were maintained in cultureconditions similar
toMDM or when stimulated with PHA, cultivated in the
presence of 11,2, and infected with aT lymphocytotropic isolate
of HIV (data not shown) .
Thus, IL6 represents a new HIVinductive cytokine for
infected cells ofthe monorytic lineage, which have been pre-
viously described as important in vivo targets of infection
(1) . Because of the broad range of susceptibilities to HIV in-
fection observed withMDM obtained from different donors,
we further investigated the inductive effects of IL6 on HIV
expression by using the chronically infected monorytic cell
line U1, which in our experience gave muchmore consistent
results from experiment to experiment (32-34) . Similar to
the primary infected macrophages, HIV expression is induc-
ible in Ul cells by TNF-a (34, 35) and by GM-CSF (2) .
11,6 Induction of HIV Expression in Chronically Infected
Promonocytic Cells. The chronically infected U1 cells were
exposed to various concentrations (from 0.1 to 1,000 U/ml)
ofrhIL6 ; cell viability and virus production were monitored
daily up to 12 d after treatment with an individual cytokine.
Maximal stimulation ofHIV production was observed with
100U/ml ofIL6 occurring between 72 and 96 h after stimu-
lation (Fig. 2) . As little as 1 U/ml of 11,6 was capable of
inducing viral expression inU1 cells (Fig. 2), whereas cytokine
concentrations higher than 100 U/ml did not result in a fur-
ther increase of HIV production . No cellular toxicity was
observed in IL6-treated U1 cells at any IL6 concentrations
tested, as determined by trypan blue dye exclusion criteria
(>95% viable cells throughout the 7-d culture period) . Fur-
thermore, 11,6 upregulated viral expression from U1 cells to
levels comparable to those induced by TNF-ca (Fig. 2) and
GM-CSF (not shown) . A second chronically infected pro-
monorytic cell line, U33.3, unlike U1 cells, constitutively
expresses detectable amounts of virus (500-1,000 rpm/p.l of
Figure 2 .
￿
11,6 induction of HIV expression in promonocytic U1
cells . Culture supernatants from unstimulated and cytokine-stimulated
cells were harvested after 72 h of culture. The results shown are
mean of triplicate cultures (variability among replicates was always
<15%) and are representative of at least five independent experiments.RT activity) (34) . HIV expression in U33.3 cells was also
inducible by IL6 andTNF-a (data not shown) . Aswe previ-
ously observed in infected primary T cells, IL6 (up to 1,000
U/ml) was not capable of affecting HIV production by the
T lymphocytic cell line ACH-2 (data not shown) .
11,6 Synergizes with TNF-a in the Upregulation ofHIV
Expression in U1 Cells. Having established that multiple cy-
tokines were capable individually of upregulating HIV ex-
pression in chronically infected promonocytic cells, we in-
vestigated the possibility that simultaneous stimulation of
U1 cells with IL6 and TNF-ac (co-stimulation) could result
in further increases in virus production . We observed that
co-stimulation of these cells with 100U/ml of IL6 andTNF-a
resulted in a synergistic induction of HIV expression (Fig .
3 A) . Incubation ofU1 cells for 72 h in the presence of 100
U/ml of 1176 and 100 U/ml of TNF-ac resulted in -65-fold
stimulation (up to 100-fold in other experiments) ofHIV
expression over the constitutive levels, whereas individual in-
cubation of U1 cells with the two cytokines led to a N10-
fold RT increase (Fig . 3 A) . In addition to RT, both IL6
and TNF-a induced synthesis of specific HIV proteins that
were virtually undetectable in unstimulated conditions, as de-
termined by Western blot analysis (Fig. 3 B) . Co-stimulation
ofU1 cells with 100 U/ml each of IL-6 and TNF-a resulted
in an increased intensity of the expressed bands as well as
in the appearance of additional bands corresponding to s
HIV proteins (Fig . 3 B), reflecting the synergistic induction
ofRT activity in the culture supernatants . Suboptimal con-
centrations of IL6 (1 U/ml) were still effective in synergizing
with TNF-ca . Both the direct and the synergistic effects of
these rytokines on HIV expression were confirmed by in-
direct immunofluorescence and by neutralization studies which
indicated that polyclonal and monoclonal anti-11r6 and anti-
TNF-ca Ab were capable of suppressing both the direct and
the synergistic effects of IL-6 andTNF-a stimulation on HIV
expression (data not shown) .
We have also investigated whether combinations of cy-
tokines could further enhance the levels ofHIV replication
in acutely infected primaryMDM cultures, as compared with
single cytokine treatments . We have not observed significant
enhancement of HIV production in these cells by any com-
bination of exogenous cytokines, thus far. However, it has
been previously reported that HIV infection ofMDM in-
duces secretion ofboth TNF-ac (36, 40) and IL6 (27), which
could act both synergistically with exogenous cytokines as
well as in an autocrine/paracrine manner (14, 15, 34, 41),
in maximizing the levels ofHIV production in these culture
conditions. In this regard, we have also observed production
of IL6 in long-term (more than 30-d-old) MDM-infected
cultures as well as reduced HIV replication inMDM treated
with anti-IL-6 or antiTNF-a Ab (Poll, G ., J . S . Justement,
A . Kinter, and A . S. Fauci, unpublished observations) .
IL6 Induction ofViralExpression in UI Cells Is Not Associated
with Increased Levels ofSteady-StateHIVRNA . To investigate
whether induction ofHIV expressionby IL6 alone was medi-
ated by an increased transcription of viral RNA, as previ-
ously demonstrated for TNF-a (11-13), we compared the
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Figure 3 .
￿
Synergistic induction of HIV expression in U1 cells co-
stimulated with 11,6 and TNF-a . (A) Culture supernatants were har-
vested after 72 h of culture in the presence of cytokines . (B) Western
blot analysis performed on cell lysates obtained from U1 cells 48 h
after stimulated with cytokines or PMA .
levels of total HIV RNA present in U1 cells stimulated by
these rytokines . TNF-a induced substantial amounts ofHIV
RNA (Fig. 4 A), whereas IL6 did not induce a significant
accumulation ofHIVRNA over the constitutive levels . How-
ever, HIV protein expression was induced to comparable levels
by 11,6 and TNF-a (Fig . 4 B) . In contrast, when U1 cells
were co-stimulated with IL6 and TNF-ac, a synergistic ac-
cumulation ofHIV RNA was observed in association with
enhanced HIV protein production (Fig. 4, A and B) . RNA
slot blot analysis confirmedboth the lack ofinduction ofHIV
RNA following stimulation with IL-6 alone and the syner-
gistic accumulation of viral RNA in U1 cells co-stimulated
with IL6 and TNF-ca (data not shown) .Figure 4.
￿
Synergistic induction of HIVRNA by co-stimulation of
U1 cells with 11,6 and TNF-a . (A) Northern blot analysis of total
HIV RNA extracted from: (Lane 1) unstimulated cells; (lane 2) cells
stimulated with IL6 ; (lane 3) cells stimulated with TNF-a ; (lane 4)
cells co-stimulated with IL6 and TNF-a . HIV RNA was detectable
after 72 h of stimulation exclusively in U1 cells that had been co-
stimulated with IL6 and TNF-at (lane 4), but not with TNF-ci alone
(lane 3) . Similar results were obtained when lower concentrations
(100 U/ml) of TNF-ci were used alone or in combination with IL6
(data not shown) . (B) Direct IL6 induction of viral proteins, but not
of HIV RNA . The relative amounts of RNA are represented as areas
(mmz) under the curve obtained by densitometric laser scanning of
the HIV specific RNA bands shown in Fig. 3 A after 24 h of stimu-
lation. The amounts of p24 released in the culture supernatants 72 h
after cytokine stimulation were calculated by interpolation of the op-
tical density (OD) values of the culture supernatants with a standard
antigen curve, both measured with the same ELISA apparatus.
Costimulation of U1 cells with 11,6 and TNF-ci resulted in a syner-
gistic production of HIV p24 antigen that saturated the maximal op-
tical capacity (equivalent to -400 ng/ml) of the ELISA reader.
11,6 and TNF-a Synergize at the Transcriptional Level to Up-
regulate HIV Expression. To determine whether the syner-
gistic increase in HIV expression detectable at the protein,
RT, andmRNA levels was correlated with an increased rate
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ofHIV transcription, nuclear run-on analysis was performed
on U1 cells stimulated with various cytokines alone or in
combination. TNF-ci stimulation induced transcription of
new HIV RNA three-fourfold over the unstimulated con-
trol, whereas 11,6 treatment alone did not significantly change
the baseline transcriptional levels (Fig. 5) . However, co-
stimulation of U1 cells with M .6 and TNF-a resulted in a
synergistic increase ofHIV transcription (N10-fold over the
unstimulated controls) . To verify that these results were at-
tributable to actual transcriptional changes, parallel experi-
ments were performed with nuclei isolated from stimulated
U1 cells that were incubated with the transcriptional inhibitor
a-amanitin, which almost entirely suppressed transcription .
Discussion
In the present studywe have demonstrated that the cytokine
IL6, which plays an-important immunoregulatory role at mul-
tiple levels oftheimmune response (14, 15), directly upregu-
lates the production of HIV in primary infected MDM as
well as in chronically infected monocytic cells. In contrast,
IM was not effective in modulating either the susceptibility
of primary T cells toHIV infection or the induction of virus
expression in chronically infected T cell lines. In addition,
IL6 synergizes in the induction ofviral expression in U1 cells
co-stimulated withTNF-a, which was previously described
as a potent HIV inductive cytokine (3-5, 11-13, 34-36) . Syn-
ergy between cytokines is a well-recognized mechanism of
modulation of the normal immune response (14, 41) . The
present observation that certain ofthese cytokines can syner-
gistically induceHIV expression in chronically infected cells
Figure 5.
￿
Synergistic transcriptional induction of HIVRNA in U1
cells co-stimulated with IL6 and TNF-a. Nuclear run-on analysis
was performed on isolated nuclei obtained from U1 cells after 17 h of
stimulation with 11,6, TNF-a, or combination of the two cytokines.
Densitometric laser scanning values are reported as relative ratios of
HIV RNA over the equivalent levels of A-actin RNA.indicates that HIV mimics the normal homeostatic mecha-
nisms utilized by the immune system to upregulate its own
gene expression. In this regard, cytokines such as IL6 and
TNF-oi are known to function in an autocrine/paracrine
manner to modulate the stateof activation ofcertain immune
competent cells (14, 15, 41). Of interest, we have recently
observed that TNF-a can induce expression ofHIV in chron-
ically infected T lymphocytic and monocytic cellsin an auto-
crine fashion (34). We are currently investigating whether
a similar mechanism is demonstrable for IL6.
At the molecular level, we and others have demonstrated
that the inductive effect of TNF-ct on HIV expression in-
volves the activation of the cellular transcription factor NF-
kB (10-13), which is a pleiotropic mediator of tissue-specific
and cellular gene function (8, 9). In contrast, IL6 stimula-
tion induces expression of viral proteins and production of
RT activity to levels comparable to that of TNF-a, but un-
like TNF-a, does not increase significantly the levels ofsteady-
stateviralmRNA over the constitutive levels. However, co-
stimulation of U1 cells with IL6 and TNF-a results in a
synergistic enhancement of HIV expression measurableboth
at the RNA and at the protein/RT level. Nuclear run-on
analysis demonstrates that this synergistic effect occurs, at
least in part, at the transcriptional level. However, U1 stim-
ulation with IL6 alone did not lead to a significant increase
of HIV transcription. Therefore, it is likely that IL6 affects
the expression of HIV by at least two mechanisms. In the
presence ofTNF-cx, IL6 increases the levels ofviral transcrip-
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tion and of steady-state RNA, resulting in a synergistic en-
hancement of HIV expression. In the absence of TNF-a,
IL6 acts post-transcriptionally, increasing the expression of
HIV proteins and RT activity without significantly inducing
new transcription or accumulation of HIV RNA. In this re-
gard, it has been recently shown that IL-6 can affect the syn-
thesis of immunoglobulins at both the transcriptional and
post-transcriptional level (42).
The observation that IL6 upregulates the production of
HIV in vitro both directly and in synergy with other cytokines
provides a potential model to investigate the physiologic as
well as pathogenic mechanisms that influence the degree of
HIV expression in vivo. On the other hand, it has been re-
ported recently that in vitro infection ofmonocytes with HIV
induces synthesis and secretion of IL6 (27). In fact, we have
also observed IL6 production in infected primary macrophage
cultures (Poli, G., J. S. Justement, A. Kinter, and A. S. Fauci,
unpublished observations). Furthermore, increased levels of
IL6 have been demonstrated both in the plasma (28) and in
the cerebrospinal fluid (29) of HIVinfected individuals. Fur-
ther understanding of the role of IL6 and other cytokines
in the regulation ofHIV expression in infected cells may pro-
vide important insight into phenomena such as the progres-
sive increase in HIV expression and ultimately viral burden
that invariably occurs in infected individuals, and which are
associated with deterioration of immune function and clin-
ical progression towards AIDS (43).
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